Out of the Hospital, Not Out of the Woods
New research shows COVID-19 patients have a higher likelihood of heart failure post-discharge
A Win-Win: DCRI study shows pulmonary rehab in COPD patients reduces health care costs while improving patient health
Pulmonary rehabilitation is an important evidenced-based treatment to improve health and quality of life for people living with Chronic Obstructive Pulmonary Disease (COPD). Now, new research from the Duke Clinical Research Institute has shown that the benefits of pulmonary rehabilitation are likely to extend beyond the patient to reduce costs for the health care system as well – with an estimated savings of more than $5,000 per patient.
IMPACT-AFib study shows a mailer not enough to increase blood thinner use in AF patients
If you want to change patient and provider behavior to improve a patient’s health, will an informational mailer make a difference?
Immune modulator drugs improved survival for people hospitalized with COVID-19
A large randomized, placebo-controlled clinical trial led by the National Institutes of Health with support from the Duke Clinical Research Institute shows that treating adults hospitalized with COVID-19 with infliximab or abatacept – drugs widely used to treat certain autoimmune diseases – substantially improved clinical status and reduced deaths.
DCRI faculty member develops H. pylori Quality Measure to Reduce Rates of Failed Eradication
A recent paper from Duke Clinical Research Institute (DCRI) faculty on behalf of the American Gastroenterological Association (AGA) provides new tools for health care providers treating patients wi
Stroke Patients’ Rates of Declining Thrombolysis Show Race-Ethnic Disparities
A new study set out to determine the prevalence of tPA declination in a nationwide registry of acute ischemic stroke (AIS) patients and to investigate differences in declination by race-ethnicity. The results appear in a paper in the February 28 issue of Neurology entitled ‘Race-Ethnic Disparities in Rates of Declination of Thrombolysis for Stroke.’
Evaluating Fitness-for-Use of Electronic Health Records in Pragmatic Clinical Trials
A recent publication reports on an analysis of how study-specific fitness-for-use was addressed amongst pragmatic clinical trials that utilize real-world data (RWD), and makes recommendations to de
Indications of Moral Injury Similar between Combat Veterans and COVID-19 Health Care Workers
COVID-19 health care workers experienced high rates of potential moral injury that are comparable to rates among military veterans, according to a collaborative study between Duke University, Vanderbilt University, and the Department of Veterans Affairs (VA).
ACC22: Investigational Anti-Clotting Drug Reduces Bleeding Risk Among AF Patients
A new type of anti-clotting drug caused fewer bleeding incidents among patients with atrial fibrillation than the commonly prescribed apixaban, according to results from a head-to-head comparison of the two. The study, led by cardiologists at the DCRI, was reported April 3 at the American College of Cardiology annual scientific sessions meeting and simultaneously published in the journal The Lancet.
ACC22: Investigational Drug for Heart Failure has Little Impact on Exercise Tolerance
Heart failure patients taking the investigational drug omecamtiv mecarbil, which has been previously shown to improve long-term outcomes, see little impact on their ability to exercise compared to a placebo, according to a study supported by the Duke Clinical Research Institute.